典型文献
Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle
文献摘要：
Pancreatic ductal adenocarcinoma (PDAC), the most commonly reported form of pancreatic cancer, is a lethal malignancy that con- tributes to the global cancer burden with high morbidity and mor- tality [1] . It has a poor 5-year survival mainly because PDAC poses a significant diagnostic challenge, has a high metastatic rate at di- agnosis and is stubbornly resistant to therapy [2] .
文献关键词：
中图分类号：
作者姓名：
Pratibha Malhotra;Ranjith Palanisamy;Marco Falasca
作者机构：
Metabolic Signalling Group,Curtin Medical School,Curtin Health Innovation Research Institute,Curtin University,Perth,WA,6102,Australia
文献出处：
引用格式：
[1]Pratibha Malhotra;Ranjith Palanisamy;Marco Falasca-.Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle)[J].国际肝胆胰疾病杂志(英文版),2022(01):4-6
A类：
agnosis,stubbornly
B类：
Targeting,pancreatic,ductal,adenocarcinoma,New,therapeutic,options,ongoing,battle,Pancreatic,PDAC,most,commonly,reported,form,cancer,lethal,malignancy,that,con,tributes,global,burden,high,morbidity,tality,It,has,poor,year,survival,mainly,because,poses,significant,diagnostic,challenge,metastatic,rate,resistant,therapy
AB值：
0.680174
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
